title: [Belimumab. A new targeted therapeutic option for lupus erythematosus].
authors.affiliation: Hautklinik, Universitätsklinik Schleswig-Holstein, Campus Kiel, Schittenhelmstr. 7, 24105, Kiel, Deutschland. rglaeser@dermatology.uni-kiel.de
authors.forename: R
authors.initials: R
authors.lastname: Gläser
mesh_terms: D000911:Antibodies, Monoclonal / Q000008:administration & dosage*; D061067:Antibodies, Monoclonal, Humanized; D053264:B-Cell Activating Factor / Q000037:antagonists & inhibitors; D001402:B-Lymphocytes / Q000187:drug effects / Q000473:pathology; D016503:Drug Delivery Systems; D006801:Humans; D008180:Lupus Erythematosus, Systemic / Q000188:drug therapy* / Q000235:genetics / Q000276:immunology
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D053264:B-Cell Activating Factor; C505719:TNFSF13B protein, human; C511911:belimumab